To conclude, our study aimed to investigate whether levels of uIAPP and total IAPP in CSF and plasma are altered in AD patients and if these levels are associated with AD biomarkers, cognitive decline and BBB permeability. This evidence concerns the gene IAPP and Mental deterioration.